Skip to main content
logo
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.880
+0.080 (1.67%)
At close: Mar 11, 2026, 4:00 PM EDT
4.880
0.00 (0.00%)
After-hours: Mar 11, 2026, 6:30 PM EDT

ADC Therapeutics Revenue

In the year 2025, ADC Therapeutics had annual revenue of $81.36M with 14.85% growth. ADC Therapeutics had revenue of $23.06M in the quarter ending December 31, 2025, with 36.36% growth.

Revenue (ttm)
$81.36M
Revenue Growth
+14.85%
P/S Ratio
7.62
Revenue / Employee
$307,008
Employees
265
Market Cap
619.98M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202581.36M10.52M14.85%
Dec 31, 202470.84M1.28M1.84%
Dec 31, 202369.56M-140.35M-66.86%
Dec 31, 2022209.91M175.99M518.89%
Dec 31, 202133.92M--
Dec 31, 2020---
Dec 31, 20192.34M1.20M105.26%
Dec 31, 20181.14M-663.00K-36.77%
Dec 31, 20171.80M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ADCT News

More News